Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD): Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief
California. clinicaltrials.gov
This story published in Digestive Health SmartBrief on 10/29/2008
More from SmartBrief:
GERD patients report nighttime symptoms, sleep problems
Wednesday, September 23, 2009
Heartburn drug meets main goal of midstage trial
Wednesday, November 18, 2009
Lifestyle tips to relieve GERD symptoms
Wednesday, September 9, 2009
Get stories like these delivered daily for FREE:
|
Digestive Health SmartBrief
From the American College of Gastroenterology and its member physicians, Digestive Health SmartBrief is a free, twice-weekly newsletter. It provides news and information for your digestive health, including stories on healthy living, developments in diagnosis and treatment, and important legislation shaping the health care landscape. You'll also find a clinical trial monitor, patient perspectives, and a resource center. Come sign up today. Learn more |
|